The second promising concept is creating redox-directed anticancer prodrugs that convert to active parent drugs in vivo by antioxidant enzymes that are specifically overexpressed in cancer
Additionally, some incidents go unreported due to other underlying health conditions
Safety Profile and Side Effects BPC-157 exhibits a favorable safety profile in available studies: Preclinical Toxicity : No lethal dose identified
To understand why thats a big deal, think of your eyeball like a camera and your brain as a computer
CrossRef The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7 Yan Lu, Lina Yu, Minlan Yang, Xiangshu Jin, Zhijing Liu, Xiaowei Zhang, Liping Wang, Dongjing Lin, Yuanyuan Liu, Min Wang, Chengshi Quan Molecular and Cellular Biochemistry.2014
The scientific community consensus maintains that until well-designed clinical trials are conducted, BPC-157 should be considered investigational